30 results on '"Tang, Wei-Guo"'
Search Results
2. Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma
3. ASAP2 interrupts c-MET-CIN85 interaction to sustain HGF/c-MET-induced malignant potentials in hepatocellular carcinoma
4. Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma
5. ABT-199 inhibits Hedgehog pathway by acting as a competitive inhibitor of oxysterol, rather as a BH3 mimetic
6. Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
7. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
8. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma
9. Proline‐rich transmembrane protein 2–negative paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 163 patients
10. PDXliver: a database of liver cancer patient derived xenograft mouse models
11. Novel Mutations in the CYP7B1 Gene Cause Hereditary Spastic Paraplegia
12. Four novel mutations in the GCH1 gene of Chinese patients with dopa-responsive dystonia
13. Meta-Analysis of Visual Evoked Potential and Parkinson’s Disease
14. Far upstream element-binding protein 1 facilitates hepatocellular carcinoma invasion and metastasis.
15. HSP4 triggers epithelial‐mesenchymal transition and promotes motility capacities of hepatocellular carcinoma cells via activating AKT.
16. Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma.
17. Identification of FOS as a Candidate Risk Gene for Liver Cancer by Integrated Bioinformatic Analysis.
18. Establishment of a hepatocellular carcinoma patient‐derived xenograft platform and its application in biomarker identification.
19. Differential network analysis depicts regulatory mechanisms for hepatocellular carcinoma from diverse backgrounds.
20. New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer.
21. Long non-coding RNA 00607 as a tumor suppressor by modulating NF-κB p65/p53 signaling axis in hepatocellular carcinoma.
22. Differentially expressed miRNAs in hepatocellular carcinoma cells under hypoxic conditions are associated with transcription and phosphorylation.
23. Dietary, circulating beta-carotene and risk of all-cause mortality: a meta-analysis from prospective studies.
24. A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinoma.
25. The Phenotypic and Genetic Spectrum of Paroxysmal Kinesigenic Dyskinesia in China.
26. MicroRNA-19a-3p regulates cell growth through modulation of the PIK3IP1-AKT pathway in hepatocellular carcinoma.
27. KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition.
28. Long non-coding RNA00364 represses hepatocellular carcinoma cell proliferation via modulating p-STAT3-IFIT2 signaling axis.
29. Depression, anxiety, and quality of life in paroxysmal kinesigenic dyskinesia patients.
30. Association between whole grain intake and all-cause mortality: a meta-analysis of cohort studies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.